New experimental vaccine for Lou Gehrig's disease gets EU funding
4.8
$ 7.99
In stock
(232)
Product Description
Runner to Conquer 7 Scottish 'Munros' Each Day to Honor Dad With ALS
Health
Knowledge-based approaches to drug discovery for rare diseases
Navy Officer Fights for Right to Try Unproven Drugs Before Dying
New experimental vaccine for Lou Gehrig's disease gets EU funding
New experimental vaccine for Lou Gehrig's disease gets EU funding
Amyloid Oligomers: A Joint Experimental/Computational Perspective
Most Experimental Drugs are Tested Offshore–Raising Concerns about
Gene therapy for ALS: A review: Molecular Therapy
News Research UC Berkeley
Fall 2022 Magazine Wallace H. Coulter Department of Biomedical
Amylyx Prices Newly Approved ALS Drug at $12,500 a Month - WSJ
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients
How Close Are We to Curing ALS? A Review of Biotech's Efforts
New experimental vaccine for Lou Gehrig's disease gets EU funding
